Helicobacter-pylori-assoziierte gastrointestinale Schleimhautläsionen: Besteht ein erhöhtes Risiko unter Therapie mit nichtsteroidalen Antirheumatika? (Helicobacter-pylori-associated gastrointestinal mucosal lesions: Does treatment with NSAID increase the risk?)

Abstract

The main cause for gastrointestinal mucosal lesions is H.P. infection (> 90%). A general mucoprotective therapy in patients with H.P. infection and NSAID therapy cannot be supported. It may be supposed that a part of mucosal lesions connected to NSAID-therapy in recent decades probably was the consequence of H.P. infections. Eradication of H.P. might be of higher importance in the future.